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ABSTRACT 
 
Angela M. Sparrow: Effects of Food Availability and Administration of Orexigenic and 
Anorectic Agents on Elevated Ethanol Drinking Associated with Drinking in the Dark 
Procedures 
(Under the direction of Dr. Todd E. Thiele) 
 
Drinking in the dark (DID) procedures have recently been developed to induce 
high levels of ethanol drinking in C57BL/6J mice, which result in blood ethanol 
concentrations reaching levels that have measurable affects on physiology and/or 
behavior. The present study determined if increased ethanol drinking associated with 
DID procedures may be motivated by caloric need rather than by the post-ingestive 
pharmacological effects of ethanol. To this end, a) the effects of food deprivation on 
ethanol consumption during DID procedures was assessed, or b) mice were given 
intraperitoneal injection of the orexigenic peptide ghrelin or the anorectic protein leptin 
before DID procedures. Neither food deprivation nor administration of orexigenic or 
anorectic compounds significantly altered ethanol drinking with DID procedures. The 
present observations are inconsistent with the hypothesis that C57BL/6J mice 
consume large amounts of ethanol during DID procedures in order to satisfy a 
caloric need. 
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CHAPTER 1 
 
INTRODUCTION 
 
What is binge drinking? 
 Bing drinking has been defined by the National Institute on Alcohol Abuse 
and Alcoholism (NIAAA, 2004) as a pattern of alcohol drinking that produces blood 
alcohol concentrations (BACs) or 0.08 gram percent or above. This would 
correspond to about 5 alcoholic beverages for males and 4 alcoholic beverages for 
females over a 2-hour period. Binge drinking is also different from “risky” drinking, 
which is consuming enough alcohol to produce BACs between 0.05 and 0.08 gram 
percent and a drinking “bender”, which is 2 or more days or heavy drinking (NIAAA, 
2004). Binge drinking has become an important subject for researchers to study 
because it is a country-wide problem and in addition, the number of binge drinking 
episodes in U.S. adults has steadily increased over the years (Naimi et al., 2003). 
Many risks are associated with binge drinking such as an increased risk of injury and 
increased violent and aggressive behavior (Brewer et al., 2005). Binge drinking in 
adults causes impaired judgment and increases risky behaviors such as driving 
while intoxicated (Flowers et al., 2008). In addition, binge drinking can produce long-
term health consequences such as an increased risk of developing metabolic 
syndrome, heart disease and type II diabetes (Fan et al., 2008) and binge drinking 
has also been associated with increased mental distress and a decreased quality of 
life (Okoro et al., 2004). Perhaps most alarming is the finding of increased risk for 
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developing alcohol dependence in individuals that binge drink early in life (Miller et 
al., 2007; Hingson et al., 2006; Hingson et al., 2005). For all of these reasons, it is 
important that researchers study binge drinking and find ways to decrease the 
instances of binge drinking among U.S. adults. 
Animal models of binge drinking 
To assist in identifying the genetic and neurobiological factors that underlie 
alcoholism, scientists often turn to animal models to address question that cannot be 
ethically studied in human subjects.  However, in many cases rodents do not consume 
enough alcohol to reach the point of behavioral and/or pharmacological intoxication 
(Spanagel, 2000). Recently, “drinking in the dark” (DID) procedures have been 
developed to induce excessive binge-like ethanol drinking in C57BL/6J mice, which 
result in blood ethanol concentrations (BECs) reaching levels that have measurable 
effects on physiology and/or behavior (Rhodes et al., 2005; Rhodes et al., 2007). DID 
procedures involve giving C57BL/6J mice access to a 20% ethanol solution for 2 to 4-
hours starting 3-hours into their dark cycle. C57BL/6J can achieve BECs of >100 mg% 
and exhibit signs of behavioral intoxication as measured by motor deficits on the 
rotarod and balance beam (Rhodes et al., 2005; Rhodes et al., 2007). Pretreatment 
with naltrexone or the dopamine re-uptake inhibitor GBR 12909 attenuate increased 
ethanol consumption associated with DID procedures, suggesting a role for opioid and 
dopamine receptor signaling (Kamdar et al., 2007). More recently, we have found that 
pretreatment with the CRF1 receptor antagonist CP-154,526 protected against high 
levels of ethanol drinking associated with specific DID procedures. Importantly, CRF1 
receptor blockade did not alter ethanol drinking in C57BL/6J mice consuming 
 3 
moderate amounts of ethanol, suggesting that CRF1 receptor signaling specifically 
modulates high ethanol intake (Sparta et al., 2008). 
The caloric need hypothesis 
As DID procedures involve providing C57BL/6J mice with access to ethanol 
towards the beginning of the dark cycle, increased ethanol drinking may be related to 
the high level of nocturnal ingestive behavior that is characteristic of mice (Ho and 
Chin, 1988; Tabarin et al., 2007). In fact, the highest levels of food intake in mice were 
found to occur during the first 4 hours of their 12 hour dark cycle (Tabarin et al., 2007), 
a window of time in which mice are given access to ethanol using DID procedures 
(Kamdar et al., 2007; Rhodes et al., 2005; Rhodes et al., 2007). Since ethanol contains 
calories, this raises the possibility that increased ethanol drinking associated with DID 
procedures results from presenting ethanol during a time of high caloric need, rather 
than an increased motivation to drink ethanol for its post-ingestive pharmacological 
effects.  
The experiments described below assessed the possibility that increased 
ethanol drinking with DID procedures stems from caloric need. In Experiment 1, we 
reasoned that if ethanol were the only source of calories during DID procedures, 
ethanol intake would be increased relative to mice with free access to food if the 
caloric need hypothesis is correct. To further test this caloric need hypothesis, in 
Experiment 2 mice were given intraperitoneal (i.p.) injection of ghrelin immediately 
before DID procedures. Ghrelin is an orexigenic gut peptide shown to increase food 
consumption when given peripherally to C57BL/6J mice (Wang et al., 2002). We 
predicted that if increased ethanol drinking resulting from DID procedures was 
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related to increased caloric need, an orexigenic peptide such as ghrelin should 
further augment ethanol intake. In Experiment 3, we determined if the protein leptin 
would influence ethanol intake when given before DID procedures. Leptin is 
synthesized in adipose tissue and reduces food intake when administered 
peripherally (Halaas et al., 1995; Prpic et al., 2003). If increased ethanol intake with 
DID procedures stems from caloric need, we predicted that the anorectic protein 
leptin should decrease ethanol intake. In Experiment 4, we examined the normal 
consummatory behaviors of C57BL/6J mice with a caloric substance (standard 
rodent chow) and a non-caloric substance (0.05% saccharin solution) over a twelve-
hour period, which included the timeframe that mice were given ethanol during DID 
procedures. Data from the experiments described below are inconsistent with the 
hypothesis that increased ethanol drinking stemming from DID procedures results 
from increased caloric need.  
CHAPTER 2 
METHODS 
Animals  
Male C57BL/6J mice (Jackson Laboratory, Bar Harbor ME) were used in all 
experiments. Mice were 6-8 weeks old when they arrived from the vendor and weighed 
between 25-30 g at the onset of the experiments. Mice were single housed in 
polypropylene cages with corncob bedding. Standard rodent chow (Teklad, Madison, 
WI) and water were available at all times except where noted. The vivarium rooms 
were maintained at an ambient temperature of 22º C with a reverse 12-hour/12-hour 
light-dark cycle.  Lights came on at 9:00 P.M. and went off at 9:00 A.M. Mice were 
acclimated to the environment for at least 10 days before the start of experiments. All 
experimental procedures were approved by the University of North Carolina Animal 
Care and Use Committee (IACUC) and were in compliance with the NIH Guide for 
Care and Use of Laboratory Animals. 
Experiment 1: Effects of Food Deprivation on Ethanol Intake Associated with 
DID Procedures 
Before the start of the experiment, mice were divided into groups (n = 10⁄ 
group) based on bodyweight so that the average weight between groups was 
similar. All mice underwent a modified DID protocol (Rhodes et al., 2005; Sparta et 
al., 2008). Briefly, all homecage water bottles were replaced with a single bottle of 
20% (v ⁄ v) ethanol, 3-hours into the start of the dark phase. The 20% ethanol 
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solution remained on the homecage for 2-hours during the training sessions (days 1 
to 3) and for 4-hours on the test day (day 4). For each of the 4-days during DID 
procedures, 1 group of mice had ad libitum access to food (no food deprivation), the 
second group of mice had food removed from their cages 3-hours before the 
beginning of the dark cycle, the third group of mice had food removed from their 
cages at the beginning of the dark cycle, and the fourth group of mice had food 
removed from their cages beginning 3-hours into the dark cycle. For all food 
deprived groups, food was returned 7-hours into the dark cycle. With this 
arrangement, mice were food deprived for 0, 6 to 8, 3 to 5, or 0 to 2 hours during 
DID procedures on days 1 to 3 and 0, 6 to 10, 3 to 7, or 0 to 4 hours during DID 
procedures on day 4. Immediately following the 4-hours of ethanol access on day 4, 
tail blood samples (6 µl) were collected from all mice to determine BECs with an 
alcohol analyzer (Analox Instruments, Lunenburg, MA). On each day of study, 
ethanol consumption and body weight measures were recorded and the amount of 
ethanol consumed was calculated as g of ethanol consumed per kg of body weight 
(g ⁄ kg). 
Experiment 2: Effects of Ghrelin Injection on Ethanol Intake Associated with DID 
Procedures and Basal Food Consumption 
The DID procedures were similar to those described above. Because ghrelin is 
a potent orexigenic agent that stimulates food intake when given peripherally (Chen et 
al., 2004; Wang et al., 2002), food was removed from all mice cages immediately 
before ethanol access on each of the 4-days of DID procedures. This was done to 
avoid the potential confound of altered ethanol drinking secondary to increased food 
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intake. To habituate mice to i.p. injections, all mice received an i.p. injection of 0.9% 
saline (5 ml/kg) for two days prior to the start of the experiment and immediately before 
ethanol access on days 1-3. Mice were then distributed into 3-groups (n = 10/group) 
matched for average ethanol consumption that occurred over the first 3-days of the 
experiment (that is, the mice were distributed so that the baseline level of ethanol 
consumption was approximately equal between the groups). On the fourth day, mice 
were given an i.p. injection of one of three doses (0, 10, or 30 g/kg) of mouse ghrelin 
(Phoenix Pharmaceuticals, Inc., Burlingame, CA) mixed in 0.9% saline immediately 
before application of the ethanol bottle. The 30 g/kg dose of ghrelin has been shown to 
significantly increase 4-hour food intake by mice (Chen et al., 2004). Tail blood (6 µl) 
was collected from all mice immediately following the 4-hour test session to determine 
BECs. Ethanol consumption and body weight measures were recorded and the 
amount of ethanol consumed was calculated as g of ethanol consumed per kg of body 
weight (g/kg).  
To confirm that ghrelin was physiologically active, a naïve group of C57BL/6J 
mice were used to assess the effects of ghrelin on food intake. Mice were distributed 
into 2-groups (n = 10/group) based on body weights. The mice received 2-days of 
habituation injections of 0.9% saline. On the test day, the food in each mouse cage 
was weighed at 3-hours into the dark cycle. At that time, mice were given an i.p. 
injection of saline or ghrelin (30 mg/kg). Food was weighed 4-h later and food 
consumption was calculated as g consumed over the 4-hour test. 
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Experiment 3: Effects of Leptin Injection on Ethanol Intake Associated with 
DID Procedures and Basal Food Consumption 
 The procedures were similar to those in Experiment 2. Because leptin reduces 
food intake, food was removed from mice cages just before i.p. injections to avoid any 
confounds associated with altered ethanol drinking secondary to changes in food 
intake. Just before the beginning of the dark cycle, mice received an i.p. injection of 
15mM HCl mixed with 7.5mM NaOH in saline (16 ml/kg, the vehicle used for leptin) 
for 2-days prior to the start of the experiment and on days 1-3 of the experiment to 
habituate them to the injection procedures. Mice were then distributed into 2-groups 
(n = 10/group) matched for average ethanol consumption that occurred over the first 3-
days of the experiment. On the fourth day, mice were given an i.p. injection of vehicle 
or mouse leptin (20 µg/g mixed in 0.9% saline containing 15mM HCl and 7.5mM 
NaOH; Calbiochem, San Diego, CA) immediately before lights out. We chose to 
given leptin at the beginning of the dark phase rather than just before ethanol access 
because the actions of this dose of leptin on food last for up to 24-hours (Prpic et al., 
2003). Ethanol bottles were placed on the cages 3-hours into the dark cycle as per the 
DID schedule. Tail blood sample (6 µl) was collected from all mice immediately 
following the 4-hour test session to determine BECs. Ethanol consumption and body 
weight measures were recorded and the amount of ethanol consumed was 
calculated as g of ethanol consumed per kg of body weight (g/kg). 
 To confirm that leptin was physiologically active, a naïve group of C57BL/6J 
mice were used to assess the effects of leptin on food intake. Mice were distributed 
into 2-groups (n = 10/group) based on body weights. The mice received 2-days of 
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habituation injections (i.p.) of the leptin vehicle at the beginning of the dark cycle. Mice 
were then given an i.p. injection of vehicle or mouse leptin (20 µg/g) immediately 
before lights out and food consumption was measured starting 3-hours into the dark 
cycle and continued for 4-hours. Food consumption was calculated as g/4-hours. 
Experiment 4: Hourly Measures of Food Intake and Saccharin Consumption 
 Naïve C57BL/6J mice (n = 7) were used to assess the consummatory patterns 
of food (caloric substance) or a 0.05% (w/v) saccharin solution (non-caloric 
substance). After habituation to the environment (2-weeks), food consumption was 
measured hourly starting 1-hour before the beginning of the dark cycle and continuing 
until 11-hours into the dark cycle (thus, 4-hours before and after the normal DID testing 
period). Food consumption was calculated as g consumed for each hourly measure. 
After food measures were complete, the same mice were given 4-days of two bottle 
choice access to water and a 0.05% saccharin solution to habituate them to the novel 
tastant. Following the habituation period, hourly measures of saccharin solution were 
assessed beginning 1-hour before the beginning of the dark cycle until 11-hour into the 
dark cycle. Saccharin consumption was calculated as g consumed per kg of body 
weight (g/kg) for each hourly measure. 
Data Analysis 
All data in this report are presented as means + SEM. One-way analyses of 
variance (ANOVAs) were used to analyze ethanol consumption and BEC data from 
Experiments 1 - 3. Repeated measures ANOVAs with post hoc t-tests were used to 
analyze food and saccharin consumption in Experiment 4. Significance was accepted 
at p < 0.05 (two-tailed). 
CHAPTER 3 
RESULTS 
Experiment 1: Effects of Food Deprivation on Ethanol Intake Associated with 
DID Procedures 
 Ethanol consumption during the 2-hour access on days 1-3 of Experiment 1 are 
presented in top portion of Table 1. ANOVAs revealed no significant group differences 
in ethanol consumption during days 1-3. Ethanol consumption and blood ethanol 
concentration data from the 4-hour test day of Experiment 1 are presented in Figs. 1A 
and 1B, respectively. One-way ANOVAs performed on these data revealed no 
significant effect of food deprivation on ethanol consumption [F(3, 36) = 1.77, p = 0.17] 
or blood ethanol concentrations [F(3, 36) = 1.44, p = 0.25]. There was a significant 
correlation between the amount of ethanol consumed and blood ethanol levels [R = 
0.69, p < 0.001]. 
Experiment 2: Effects of Ghrelin Injection on Ethanol Intake Associated with 
DID Procedures and Basal Food Consumption 
Ethanol consumption during the 2-hour access on days 1-3 of Experiment 2 are 
presented in middle portion of Table 1. ANOVAs revealed no significant group 
differences in ethanol consumption during days 1-3. Ethanol consumption and blood 
ethanol concentration data from the 4-hour test day of Experiment 2 are presented in 
Figs. 2A and 2B, respectively. One-way ANOVAs performed on these data revealed 
that neither of the doses of ghrelin examined significantly altered ethanol consumption 
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[F(2, 22) = 1.06, p = 0.36] or blood ethanol levels [F(2, 22) = 1.10, p = 0.35]. There was 
a significant correlation between the amount of ethanol consumed and blood ethanol 
concentrations [R = 0.604, p = 0.001]. The effects of ghrelin on food consumption are 
presented in Fig. 3C. Administration of the 30 mg/kg dose of ghrelin significantly 
increased 4-h food consumption [F(1, 16) = 21.30, p < 0.001], verifying that this dose 
of ghrelin was physiologically active in C57BL/6J mice. 
Experiment 3: Effects of Leptin Injection on Ethanol Intake Associated with 
DID Procedures and Basal Food Consumption 
Ethanol consumption during the 2-hour access on days 1-3 of Experiment 3 are 
presented in bottom portion of Table 1. ANOVAs revealed no significant group 
differences in ethanol consumption during days 1-3. Ethanol consumption and blood 
ethanol concentration data from the 4-hour test day of Experiment 3 are presented in 
Figs. 3A and 3B, respectively. One-way ANOVAs performed on these data revealed 
that the 20 µg/g dose of leptin did not significantly alter ethanol consumption [F(1, 18) 
= 0.45, p = 0.51] or blood ethanol levels [F(1, 18) = 0.46, p = 0.50]. There was a 
significant correlation between the amount of ethanol consumed on day 4 and blood 
ethanol concentrations [R = 0.55, p = 0.01]. The effects of leptin on food consumption 
are presented in Fig. 3C. Importantly, administration of 20 µg/g dose of leptin 
significantly decreased 4-hour food consumption [F(1, 8) = 107.88, p < 0.001], verifying 
that this dose of leptin was physiologically active in C57BL/6J mice. 
Experiment 4: Hourly Measures of Food Intake and Saccharin Consumption 
 The hourly consumption measures for food and 0.05% saccharin from 
experiment 4 are presented in Figs. 4A and 4B, respectively. Visual inspection of the 
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data reveal that C57BL/6J mice showed highest levels of food intake during the period 
of the dark cycle during which ethanol is administered with DID procedures (Fig. 4A). 
Similarly, 0.05% saccharin solution consumption reached its peak levels during the 
time period used with DID procedures (Fig. 4B). To analyze these data, we averaged 
the data into three, 4-hour blocks of time which corresponded to the 4-hour period 
before the time of DID procedures, the 4-hour period during the time of DID 
procedures, and the 4-hour period after the time of DID procedures. A repeated 
measures ANOVA performed on food intake data revealed a significant effect of time 
block [F(1, 6) = 987.95, p < 0.001]. Post hoc tests showed that food intake was 
significantly higher during the block of time corresponding to DID manipulations relative 
to either the 4-hour block of time before or after this period. Similarly, a repeated 
measures ANOVA performed on 0.05% saccharin solution data revealed a significant 
effect of time block [F(1, 6) = 221.67, p < 0.001]. Post hoc tests showed that, relative to 
the 4-hour block of time preceding the period of time used with DID procedures, mice 
drank significantly more saccharin solution during the two other blocks of time. 
CHAPTER 4 
DISCUSSION 
Because DID procedures involve providing C57BL/6J mice with limited access 
to ethanol during the time of day in which food intake is at its highest levels, it was 
possible that the high levels of ethanol drinking that are stimulated by DID procedures 
result from increased caloric need (that is, mice treat ethanol as another calorie-rich 
food source). If this caloric need hypothesis is correct, three predictions should be 
satisfied: 1) Removal of food should further augment ethanol drinking during DID 
procedures since ethanol becomes the sole source of calories, 2) pretreatment with an 
orexigenic peptide (i.e., a peptide that stimulates food intake) should further augment 
ethanol intake during DID procedures, and  3) pretreatment with an anorectic protein 
(i.e., an agent that reduces feeding) should attenuate ethanol intake during DID 
procedures. Contrary to the caloric need hypothesis, none of these predictions were 
confirmed. Thus, varying the amount of food deprivation time did not significantly alter 
ethanol drinking or blood ethanol levels. Furthermore, i.p. injection of ghrelin, a peptide 
that stimulates food intake (Chen et al., 2004; Wang et al., 2002), failed to increase 
ethanol drinking in a dose that increased food intake in C57BL/6J mice. Similarly, i.p. 
injection of leptin, a protein that attenuates feeding (Halaas et al., 1995; Prpic et al., 
2003), failed to decrease ethanol intake in a dose that reduced feeding in C57BL/6J 
mice. Taken together, these observations suggest that the high levels of ethanol 
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drinking promoted by DID procedures are unlikely motivated by caloric need, but rather 
by other factors such as the pharmacological post-ingestive effects of ethanol.  
Interestingly, during the period of time that C57BL/6J mice received ethanol with 
DID procedures, they exhibited their highest levels of food intake when measures were 
collected from 4-hours before to 4-hours after the period of time used with DID 
procedure (Fig. 4A). At first glance, this observation appears to be consistent with the 
hypothesis that high levels of ethanol intake might be related to caloric need.  
However, we also observed that C57BL/6J mice showed high levels of saccharin 
solution consumption during this same period of time (Fig. 4B). Since saccharin is a 
non-caloric compound with reinforcing properties, increased consumption of saccharin 
cannot be related to increased caloric need. An alternative explanation is that 
C57BL/6J mice exhibit an increased motivation to consume reinforcing stimuli (such as 
food, sweet flavors, and ethanol)  during the time of day that DID procedures are 
performed, and increased motivation to consume these reinforcing stimuli is 
independent of the reinforcer’s caloric content.  
The present observation that ghrelin did not alter ethanol consumption in 
C57BL/6J mice is consistent with a recent report showing that hypothalamic infusion of 
ghrelin increased food intake but did not alter ethanol drinking in Sprague-Dawley rats 
(Schneider et al., 2007). Interestingly, plasma ghrelin levels were found to be elevated 
in alcoholics relative to normal individuals (Kraus et al., 2005) and plasma ghrelin 
levels were positively correlated with self-reports of craving in alcoholics (Addolorato et 
al., 2006). These observations suggest that while ghrelin may modulate 
neurobiological pathways involved in craving, this peptide may not directly modulate 
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the ingestion of ethanol. Similarly, the present work with leptin is consistent with the 
observation that repeated daily injections of leptin failed to alter ethanol drinking in rats, 
although leptin did appear to augment deprivation-induced increases of ethanol 
drinking (Kiefer et al., 2001). However, disruption of leptin signaling in mutant mice was 
associated with reduced ethanol intake (Blednov et al., 2004). Circulating levels of 
leptin have also been found to be elevated in alcoholics, and are correlated with 
subjective reports of craving in alcoholics (Kiefer et al., 2005; Nicolas et al., 2001). 
Thus, as with ghrelin, while leptin may be involved with craving in human alcoholics, its 
role in modulating ethanol consumption in animal models remains unclear. 
In the present report, we observed BECs in C57BL/6J mice that ranged from 
approximately 100 to 150 mg%. These levels of BECs are consistent with previous 
reports that have used DID procedures (Kamdar et al., 2007; Rhodes et al., 2005; 
Rhodes et al., 2007). Because C57BL/6J mice exhibit signs of behavioral intoxication 
with BECs in this range (Rhodes et al., 2007), DID procedures appear to provide a 
valid animal model of drinking to the point of physiological intoxication, and may be 
useful for identifying targets that may be protective against binge-like ethanol drinking 
(Kamdar et al., 2007; Moore et al., 2007; Sparta et al., 2008). The present results 
further strengthen the usefulness of this model by showing that elevated drinking with 
DID procedures is unlikely related to caloric need. 
In conclusion, data obtained in the present study are inconsistent with the 
hypothesis that C57BL/6J mice consume large amounts of ethanol during DID 
procedures in order to satisfy a caloric need. Neither food deprivation nor 
administration of orexigenic or anorectic compounds significantly alter ethanol 
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drinking with DID procedures. A more likely explanation is that increased ethanol 
drinking is motivated by other factors associated with the pharmacological post-
ingestive effects of ethanol. 
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Table 1: Ethanol consumption (g/kg/2-hour) on days 1-3  
(mean + SEM) of Experiments 1-3. 
 
 Day 1 Day 2 Day 3 
Experiment 1    
0-h Food Deprivation 4.13 +/- 0.33 3.07 +/- 0.26 2.52 +/- 0.30 
0-4-h Food Deprivation 4.02 +/- 0.62 2.58 +/- 0.27 1.68 +/- 0.33 
3-7-h Food Deprivation 3.53 +/- 0.27 2.45 +/- 0.32 1.92 +/- 0.26 
6-10-h Food Deprivation 3.36 +/- 0.18 2.60 +/- 0.27 2.31 +/- 0.45 
Experiment 2    
0 g/kg Ghrelin 2.25 +/- 0.40 1.97 +/- 0.27 2.36 +/- 0.69 
10 g/kg Ghrelin 1.68 +/- 0.45 2.13 +/- 0.28 2.12 +/- 0.28 
30 g/kg Ghrelin 2.35 +/- 0.36 1.82 +/- 0.27 1.62 +/- 0.27 
Experiment 3    
0 µg/g Leptin 1.83 +/- 0.37 2.94 +/- 0.45 1.94 +/- 0.41 
20 µg/g Leptin 1.94 +/- 0.28 2.16 +/- 0.26 2.57 +/- 0.31 
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Figure 1: Consumption of 20% (v ⁄ v) ethanol by C57BL ⁄ 6J mice (A) and associated 
blood ethanol concentrations (B) during the 4-hour test day of Experiment 1. Mice 
were deprived of food for 0, 0 to 4, 3 to 7, or 6 to 10 hours during DID procedures on 
day 4, which corresponded to ad libitum access to food, or removing food at the 
initiation of DID procedures, 3-hours before DID procedures (at the beginning of the 
dark cycle), or 6-hours before DID procedures (3-hours before the beginning of the 
dark cycle). Food deprivation did not significantly alter ethanol drinking or associated 
blood ethanol concentrations. All values are means + SEM. 
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Figure 2: Consumption of 20% (v/v) ethanol by C57BL/6J mice (A) and associated 
blood ethanol concentrations (B) during the 4-hour test day of Experiment 2. 
Immediately before ethanol access, food was removed from the cages and mice 
were given an intraperitoneal (i.p.) injection of mouse ghrelin (0, 10, 30 mg/kg). 
Ghrelin did not significantly alter ethanol consumption or blood ethanol 
concentrations. Ghrelin (30 mg/kg) did significantly increase 4-hour food intake by 
C57BL/6J (C). All values are means + SEM. *p < 0.05. 
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Figure 3: Consumption of 20% (v/v) ethanol by C57BL/6J mice (A) and associated 
blood ethanol concentrations (B) during the 4-hour test day of Experiment 3. 
Immediately before lights out, food was removed from the cages and mice were 
given an i.p. injection of mouse leptin (0, 20 µg/g). Leptin did not alter ethanol 
consumption or blood ethanol concentrations. A 20 µg/g dose of leptin did 
significantly reduced 4-h food intake (C). All values are means + SEM. *p < 0.05. 
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Figure 4: Hourly consumption of food (A) and 0.05% saccharin (B) from Experiment 
4. Consumption of food and saccharin solution were measured hourly for a 12-h 
period from 4-hours before to 4-hours after the 4-hour timeframe that mice received 
ethanol during DID procedures. to determine normal consummatory patterns with a 
caloric (food) and non-caloric (saccharin) substance. The dotted lines indicate the 4-
hour period of time that 20% ethanol is given to mice on the DID test day. All values 
are means + SEM. 
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